Igm Biosciences Stock Analysis

IGM Stock Analysis Notes

About 35.0% of the company shares are held by company insiders. The company recorded a loss per share of 3.61. IGM Biosciences had not issued any dividends in recent years. IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California. Igm Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 242 people. To learn more about IGM Biosciences call Fred JD at 650 965 7873 or check out https://igmbio.com.

IGM Biosciences Investment Alerts

IGM Biosciences Upcoming and Recent Events

IGM Largest EPS Surprises

View All Earnings Estimates

IGM Biosciences Environmental, Social, and Governance (ESG) Scores

IGM Stock Institutional Investors

Note, although IGM Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

IGM Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 620.21 M.

IGM Profitablity

Management Efficiency

IGM Biosciences has return on total asset (ROA) of (0.3738) % which means that it has lost $0.3738 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3211) %, meaning that it created substantial loss on money invested by shareholders. IGM Biosciences' management efficiency ratios could be used to measure how well IGM Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.61 in 2024. Return On Capital Employed is likely to drop to -0.73 in 2024. At this time, IGM Biosciences' Other Assets are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 10 M in 2024, whereas Total Assets are likely to drop slightly above 300.2 M in 2024.

Technical Drivers

As of the 2nd of December, IGM Biosciences retains the risk adjusted performance of 0.0369, and Market Risk Adjusted Performance of 0.1428. IGM Biosciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out IGM Biosciences coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if IGM Biosciences is priced fairly, providing market reflects its last-minute price of 10.79 per share. Given that IGM Biosciences has jensen alpha of 0.0102, we strongly advise you to confirm IGM Biosciences's regular market performance to make sure the company can sustain itself in the future.

IGM Biosciences Price Movement Analysis

IGM Biosciences Insider Trading Activities

IGM Biosciences Outstanding Bonds

IGM Biosciences Predictive Daily Indicators

IGM Biosciences Corporate Filings

IGM Biosciences Forecast Models

IGM Biosciences' time-series forecasting models are one of many IGM Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary IGM Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how IGM Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling IGM shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as IGM Biosciences. By using and applying IGM Stock analysis, traders can create a robust methodology for identifying IGM entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. IGM analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. IGM analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

IGM Biosciences stock analysis indicators help investors evaluate how IGM Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading IGM Biosciences shares will generate the highest return on investment. By understating and applying IGM Biosciences stock analysis, traders can identify IGM Biosciences position entry and exit signals to maximize returns.

When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.